Video Experimental Relacionado

Updated: Jul 12, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Pembrolizumab en la Práctica: Evaluación de la Seguridad y la Eficacia a Través de un Marco Retrospectivo

Shalini Thomas1, Princy Palatty1, Laxmi Govindraj1

  • 1Department of Pharmacology, Amrita Institute of Medical Science and Research Center, Amrita Vishwa Vidhyapeetham, Ernakulam, IND.

Cureus
|February 20, 2026
PubMed
Resumen

Pembrolizumab muestra una eficacia significativa en el tratamiento de diversos cánceres, con una tasa de respuesta objetiva (TRO) del 14,5% y una tasa de control de la enfermedad (TCE) del 61,3%. La mayoría de las reacciones adversas a los medicamentos fueron de leves a moderadas, lo que indica un perfil de seguridad favorable para esta inmunoterapia.

Palabras clave:
reacción adversacarcinoma de mamaeficaciahipotiroidismoinmunoterapialenvatiniboncologíainhibidor de pd-1pembrolizumabcáncer de riñón

Más Videos Relacionados

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Videos de Conceptos Relacionados

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.